LAUSANNE, Switzerland, Dec. 07, 2023 (GLOBE NEWSWIRE) — Distalmotion, a pioneer in innovative on-demand robotics, has appointed medical device industry leader Greg Roche as CEO. Subject to shareholder approval, Roche will also join the company's Board of Directors. Roche will lead Distalmotion's expansion initiatives for Dexter in the U.S. and EU.® We develop surgical robots and provide experienced insight and guidance for the next phase of the company's growth strategy.
Roche has more than 20 years of commercial and management experience in the medical technology industry and brings a wealth of expertise in the areas of laparoscopic surgery, endoscopic visualization and surgical robotics to Distalmotion.
Most recently, Roche served as CEO of Avatara Medical, furthering his leadership and experience in soft tissue robotic technologies, and prior to that he served as Global President of Robotics and Technology at Zimmer Biomet, where he led the successful global launch of ROSA.® He has driven above-market growth for the company by developing a robotic knee system and an innovative business model that meets the unique demands of ambulatory surgery centers (ASCs).Since the early 2000s, Roche has served in multiple sales and leadership roles for Stryker in the U.S. Roche is clearly positioned to bring extensive sales and marketing experience from each of these roles to Distalmotion.
“I am excited to join Distalmotion. We have an incredibly talented team that has positioned Distalmotion as a leader in the next generation of surgical robotics. I would like to thank Michael Friedrich, former CEO of Distalmotion, for laying the foundation that truly paves the way for future success and continuing in his new role as COO,” commented Roche. “Dexter is an incredible product that will enable broader access to robotic surgery. I look forward to making this innovative solution the standard of care for minimally invasive surgery and building on the body of evidence generated across nearly 800 cases and more than 35 different surgical procedures.”
“We are honored to welcome Greg to Distal Motion's executive team,” said Rick Anderson, Chairman of the Board. “Greg's global experience in the sector, track record in the U.S. and deep understanding of our market segment make him an excellent fit and position the company for an exciting future.”
About Distalmotion
Distal Motion is a medical device company founded in Lausanne, Switzerland, with a mission to set new standards in medicine through innovation in robotics technology. The company aims to bring the benefits of robotic surgery to more hospitals, more surgeons and more patients around the world. To that end, the company developed the surgical robot Dexter.®Dexter removes robotic barriers and empowers surgeons by providing exceptional technology, ultimately making best-in-class minimally invasive surgery available to more patients.
For more information, visit www.distalmotion.com and follow us on LinkedIn/Twitter: @Distalmotion.
###
-
Distalmotion Names Industry Leader Greg Roche CEO
